<DOC>
	<DOCNO>NCT01210859</DOCNO>
	<brief_summary>The purpose study check whether antimuscarinics usually broadly used treatment overactive bladder symptom effective treatment symptom insertion ureteral stent . In order study efficacy treatment OAB symptom stented patient investigator use suitable questionnary .</brief_summary>
	<brief_title>Effects Antimuscarinic Drugs Overactive Bladder ( OAB ) Symptoms After Insertion Ureteral Stents</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Muscarinic Antagonists</mesh_term>
	<criteria>everyone underwent ureteral stent insertion start treatment detrusitol adverse affect detrusitol unwillness patient continue treatment detrusitol , cronic renal hepatic failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>detrusitol</keyword>
	<keyword>overactive</keyword>
	<keyword>bladder</keyword>
	<keyword>ureteral</keyword>
	<keyword>stent</keyword>
</DOC>